Cambria Cannabis ETF (TOKE) Dividend History

Dividend Yield: 5.92%
Dividend Frequency: Quarterly

Dividend History

Pay Date Amount Ex Dividend Date Record Date
June 20, 2025 $0.01 06/18/2025 06/18/2025
December 30, 2024 $0.14 12/20/2024 12/20/2024
September 30, 2024 $0.08 09/20/2024 09/20/2024
July 01, 2024 $0.05 06/21/2024 06/21/2024
April 01, 2024 $0.06 03/21/2024 03/22/2024
Show more

Dividends Summary

  • Cambria Cannabis ETF has issued 21 dividend payments over the past 6 years
  • The most recent dividend was paid 34 days ago, on June 20, 2025
  • The first recorded dividend was paid on October 7, 2019
  • The highest dividend payout was $0.28 per share
  • The average dividend over this 6 year span is $0.10 per share
  • Cambria Cannabis ETF has decreased its dividend payments by 89.18% since 2019

Company News

  • Philip Morris' Q3 Earnings Beat Puts ETFs in Focus

    Look into ETFs with an exposure in PM, as the tobacco company reports robust Q3 earnings.

    Zacks Investment Research
    Featured Companies: DURA FDL IYK PM RDIV
  • Rescheduling Cannabis: What Are The Implications For MSOs, Tax Rule 280E, FDA And Pharma?

    The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences. What is the best option for unlocking the cannabis industry's potential: exploring exemptions or legislative change? Rescheduling MMJ: FDA And Pharma Implications Tax Rule 280E poses a considerable obstacle to cannabis companies, forcing them to pay income tax on gross profits and resulting in an astronomical effective tax rate of 70% for many US plant-touching businesses. While the removal of 280E through cannabis rescheduling appears attractive, Z&A cautions against embracing this narrative without considering its potential "Pandora's Box" of consequences. Rescheduling medical marijuana (MMJ) would indeed make it federally legal, but it could also usher in stricter FDA regulations and limit prescription accessibility for doctors. Additionally, it might lead to the entrance of pharmaceutical companies, altering the industry's dynamics significantly. “Moving MMJ to Schedule II or III would make MMJ federally legal with all that implies: FDA regulation, likely tougher for Drs to prescribe, ...Full story available on Benzinga.com

    Benzinga
  • Altria: Time To Start Thinking About The End Of The Dividend

    The bad news for Altria never seems to end, with the FDA now proposing to ban JUUL E-cigarettes. Read what this could mean for MO stock.

    Seeking Alpha
    Featured Companies: DHS DIVZ FDL FORH MO WBIF WBIG XLP
  • Altria: 3 Ways To Trade Tobacco Giant

    Investing.com
    Featured Companies: CRON DHS FORH MO
  • As FB becomes META, here are 10 creative ticker symbols

    For some companies, those letters are key to building a brand identity

    MarketWatch
    Featured Companies: CAKE CGC EAT FUN HOG KO PLAY TAP WEED WOOF
Page data last updated 07/23/2025 18:33:19 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included